IL6 and metabolic dysfunction-associated steatohepatitis: In terms of inflammatory cytokines in the liver, patients with non-alcoholic steatohepatitis (NASH), currently called metabolic dysfunction-associated steatohepatitis (MASH), present higher expression of hepatic IL-6 than normal individuals; moreover, a positive correlation has been observed between hepatocyte IL-6 expression and the degree of inflammation and stage of fibrosis38.